top of page
DIGEST: Finerenone for Heart Failure, PCV21 & the Latest Pneumonia Vaccine Recs, 24-hour vs 15-hour Oxygen Therapy, & PREVENT vs PCE for Cardiovascular Risk Estimation with Dr. Alex Chaitoff, Dr. Rahul Ganatra, Dr. Matthew Watto, Dr. Paul Williams on the BackTable Curbsiders Podcast
00:00 / 01:04

Download the BackTable mobile app to watch this episode.

The Curbsiders Internal Medicine

Episode # 459  •  28 Oct 2024

DIGEST: Finerenone for Heart Failure, PCV21 & the Latest Pneumonia Vaccine Recs, 24-hour vs 15-hour Oxygen Therapy, & PREVENT vs PCE for Cardiovascular Risk Estimation

Join us as we review recent articles and news featured in The DIGEST issues #56 and #57, including finerenone for heart failure, the skinny on pneumonia vaccines and the latest, PCV21, long-term oxygen therapy (the REDOX trial), and the PREVENT vs PCE cardiovascular risk equations. Fill your brain hole with a fully digestible meal! Featuring Alex Chaitoff (@alexchaitoff), Rahul Ganatra (@rbganatra), Nora Taranto (@norataranto), and Matt Watto (@doctorwatto).

Note: **Update on Pneumonia Vaccine from ACIP: After we recorded and just before we published this episode, the CDC updated its vaccine guidance to include pneumonia vaccination for all adults aged 50 years and older to receive either PCV20, PCV21, or the combination of PCV15 followed by PPSV23 one year later (CDC site accessed 24 Oct 2024).**

Resources

You may also like

See more of the content that's relevant to your practice.

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page